| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1104 | 2019 |
| Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide‐induced multiple organ dysfunction syndrome in rats E Crespo, M Macías, D Pozo, G Escames, M Martín, F Vives, JM Guerrero, ... The FASEB Journal 13 (12), 1537-1546, 1999 | 349 | 1999 |
| Minireview: cell protective role of melatonin in the brain D Acufla‐Castroviejo, G Escames, M Macks, AM Hoyos, AM Carballo, ... Journal of pineal research 19 (2), 57-63, 1995 | 195 | 1995 |
| Electrophysiological study of the response of medial prefrontal cortex neurons to stimulation of the basolateral nucleus of the amygdala in the rat JM Perez-Jaranay, F Vives Brain research 564 (1), 97-101, 1991 | 150 | 1991 |
| Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) FJ Barrero, I Ampuero, B Morales, F Vives, J de Dios Luna Del Castillo, ... The pharmacogenomics journal 5 (2), 135-141, 2005 | 146 | 2005 |
| Comparative effects of melatonin, l‐deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro H Khaldy, G Escames, J Leon, F Vives, JD Luna, D Acuna‐Castroviejo Journal of pineal research 29 (2), 100-107, 2000 | 110 | 2000 |
| Plasma α‐synuclein in patients with Parkinson's disease with and without treatment R Duran, FJ Barrero, B Morales, JD Luna, M Ramirez, F Vives Movement disorders 25 (4), 489-493, 2010 | 105 | 2010 |
| Electrophysiological evidence that the mediodorsal nucleus of the thalamus is a relay between the ventral pallidum and the medial prefrontal cortex in the rat F Vives, GJ Mogenson Brain Research 344 (2), 329-337, 1985 | 95 | 1985 |
| Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives J Leon, F Vives, E Crespo, E Camacho, A Espinosa, MLA Gallo, ... Journal of neuroendocrinology 10 (4), 297-302, 1998 | 91 | 1998 |
| Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa A Agil, R Durán, F Barrero, B Morales, M Araúzo, F Alba, MT Miranda, ... Journal of the neurological sciences 240 (1-2), 31-36, 2006 | 80 | 2006 |
| Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole‐induced seizures L Bikjdaouene, G Escames, J Leon, JMR Ferrer, H Khaldy, F Vives, ... Journal of pineal research 35 (1), 54-60, 2003 | 78 | 2003 |
| Calcium‐dependent effects of melatonin inhibition of glutamatergic response in rat striatum G Escames, M Macias, J Leon, J Garcia, H Khaldy, M Martin, F Vives, ... Journal of neuroendocrinology 13 (5), 459-466, 2001 | 74 | 2001 |
| Beta-endorphin and ACTH in plasma: Effects of physical and psychological stress CM Oltras, F Mora, F Vives Life Sciences 40 (17), 1683-1686, 1987 | 71 | 1987 |
| The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ... Movement Disorders 34 (4), 460-468, 2019 | 70 | 2019 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 68 | 2021 |
| Neuropeptides, neuropeptidases and brain asymmetry M Ramírez, I Prieto, F Vives, M de Gasparo, F Alba Current Protein and Peptide Science 5 (6), 497-506, 2004 | 65 | 2004 |
| Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. G Escames, F Vives Neuroreport 7 (2), 597-600, 1996 | 65 | 1996 |
| Brain aminopeptidases and hypertension I Banegas, I Prieto, F Vives, F Alba, M de Gasparo, AB Segarra, ... Journal of the Renin-Angiotensin-Aldosterone System 7 (3), 129-134, 2006 | 56 | 2006 |
| Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome KR Kessler, N Hamscho, B Morales, C Menzel, F Barrero, F Vives, ... Journal of neural transmission 112, 1345-1353, 2005 | 50 | 2005 |
| Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ... Movement Disorders 35 (5), 774-780, 2020 | 49 | 2020 |
Francisco Javier Barrero HernándezUniversidad de GranadaVerified email at ugr.es
